Absci Corp (ABSI)

$2.76 -0.05 (-1.78%)
Market Cap 358.44M
Revenue (ttm) 4.53M
Net Income (ttm) -103.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,276.16%
Debt to Equity Ratio 0.02
Volume 4,191,000
Avg Vol 2,922,768
Day's Range N/A - N/A
Shares Out 127.56M
Stochastic %K 30%
Beta 2.06
Analysts Strong Sell
Price Target $9.14

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
musky54
musky54 Jun. 25 at 8:42 PM
$ABSI OK drop some news
1 · Reply
Joejoe59
Joejoe59 Jun. 25 at 5:41 AM
$ABSI https://youtube.com/shorts/eMk1reSw1BE?si=ojPTBt_pY-fmwpm4
0 · Reply
gorkha
gorkha Jun. 23 at 4:49 PM
$ABSI I have NO position. With 20% short interest and gap at 1.5. It will certainly be loading zone.
1 · Reply
Joejoe59
Joejoe59 Jun. 21 at 10:40 PM
$ABSI " Wall Street's Small- Cap AI Biotech Set to 20X in 6 years" https://youtube.com/shorts/Gj529hXBpfY?si=JQtWOtO_R3r0Lz2U
0 · Reply
flam70
flam70 Jun. 20 at 11:18 PM
$ABSI andreas busch, chied innovation officer at absci, was appointed to the board of director of Astellas Pharmaceutical. Maybe thats are large pharma deal. Just a guess
3 · Reply
musky54
musky54 Jun. 20 at 8:16 PM
$ABSI 9.7 million in volume anybody hear anything?
1 · Reply
gorkha
gorkha Jun. 20 at 5:43 PM
$ABSI why there is 20% short interest, any bear what is your thesis
1 · Reply
musky54
musky54 Jun. 20 at 3:12 PM
$ABSI what the hell was that?
1 · Reply
makedatbread88
makedatbread88 Jun. 20 at 12:45 PM
$ABSI interesting here
0 · Reply
CatRocks
CatRocks Jun. 20 at 12:32 PM
$OSCR $ABSI $GRRR also $KMX pre-market movers
0 · Reply
Latest News on ABSI
Absci to Participate in Upcoming Investor Conferences

May 20, 2025, 8:00 AM EDT - 5 weeks ago

Absci to Participate in Upcoming Investor Conferences

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 6 weeks ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 6 weeks ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 6 weeks ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 2 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Apr 3, 2025, 3:15 PM EDT - 2 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 3 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 3 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 3 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 4 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 4:00 PM EST - 4 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 4 months ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 4 months ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 5 months ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 5 months ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13, 2025, 2:05 AM EST - 5 months ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 5 months ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 6 months ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 6 months ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:01 AM EST - 8 months ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 8 months ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 8 months ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 9 months ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 3, 2024, 12:36 PM EDT - 9 months ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:50 PM EDT - 11 months ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 11 months ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 11 months ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 28, 2024, 1:24 AM EDT - 11 months ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 1 year ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 1:30 PM EDT - 1 year ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 1 year ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Absci Announces Pricing of Public Offering of Common Stock

Feb 27, 2024, 10:20 PM EST - 1 year ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Feb 27, 2024, 4:01 PM EST - 1 year ago

Absci Announces Proposed Public Offering of Common Stock

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Feb 21, 2024, 7:30 AM EST - 1 year ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Absci to Participate in the 26th Annual Needham Growth Conference

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Dec 20, 2023, 7:30 AM EST - 1 year ago

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Dec 4, 2023, 7:30 AM EST - 1 year ago

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT

Dec 3, 2023, 1:28 AM EST - 1 year ago

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT

AZN

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Nov 14, 2023, 2:16 AM EST - 1 year ago

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

Sep 21, 2023, 8:00 AM EDT - 1 year ago

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

Absci to Host R&D Day on October 4, 2023

Sep 6, 2023, 8:00 AM EDT - 1 year ago

Absci to Host R&D Day on October 4, 2023

Biotech company Absci lays off 30 employees, about 15% of staff

Sep 5, 2023, 10:40 AM EDT - 1 year ago

Biotech company Absci lays off 30 employees, about 15% of staff

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

Aug 14, 2023, 8:02 AM EDT - 2 years ago

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

musky54
musky54 Jun. 25 at 8:42 PM
$ABSI OK drop some news
1 · Reply
Joejoe59
Joejoe59 Jun. 25 at 5:41 AM
$ABSI https://youtube.com/shorts/eMk1reSw1BE?si=ojPTBt_pY-fmwpm4
0 · Reply
gorkha
gorkha Jun. 23 at 4:49 PM
$ABSI I have NO position. With 20% short interest and gap at 1.5. It will certainly be loading zone.
1 · Reply
Joejoe59
Joejoe59 Jun. 21 at 10:40 PM
$ABSI " Wall Street's Small- Cap AI Biotech Set to 20X in 6 years" https://youtube.com/shorts/Gj529hXBpfY?si=JQtWOtO_R3r0Lz2U
0 · Reply
flam70
flam70 Jun. 20 at 11:18 PM
$ABSI andreas busch, chied innovation officer at absci, was appointed to the board of director of Astellas Pharmaceutical. Maybe thats are large pharma deal. Just a guess
3 · Reply
musky54
musky54 Jun. 20 at 8:16 PM
$ABSI 9.7 million in volume anybody hear anything?
1 · Reply
gorkha
gorkha Jun. 20 at 5:43 PM
$ABSI why there is 20% short interest, any bear what is your thesis
1 · Reply
musky54
musky54 Jun. 20 at 3:12 PM
$ABSI what the hell was that?
1 · Reply
makedatbread88
makedatbread88 Jun. 20 at 12:45 PM
$ABSI interesting here
0 · Reply
CatRocks
CatRocks Jun. 20 at 12:32 PM
$OSCR $ABSI $GRRR also $KMX pre-market movers
0 · Reply
CatRocks
CatRocks Jun. 20 at 10:46 AM
$OSCR $ABSI $GRRR big pre-market movers today
0 · Reply
GSP
GSP Jun. 20 at 10:45 AM
Early look at morning gappers for Friday: $SRM $WHLR $ABSI $BIYA $GRRR .
0 · Reply
musky54
musky54 Jun. 20 at 9:45 AM
$ABSI can’t find any news anybody know?
2 · Reply
middleman
middleman Jun. 20 at 9:28 AM
$ABSI let's make some money today!
1 · Reply
Dstufggggg
Dstufggggg Jun. 20 at 9:19 AM
$ABSI what are we going to see this reach today?
0 · Reply
topstockalerts
topstockalerts Jun. 20 at 9:18 AM
Pre Market Top Gainers PT2 $PLAG $GMS $CMCM $WLGS $ABSI
0 · Reply
Bobaloo66
Bobaloo66 Jun. 20 at 8:04 AM
$ABSI sweet
0 · Reply
gorkha
gorkha Jun. 19 at 1:53 AM
$ABSI when is the next ER?
1 · Reply
Dstufggggg
Dstufggggg Jun. 18 at 7:38 PM
$ABSI when are we likely to see a spike? Id love some good returns on this!
3 · Reply
DinoTradez
DinoTradez Jun. 18 at 6:53 PM
$ABSI Newbie here how long approximate to Interim Phase 1 Data and that AMD partnership from Q4 then who the new additional large pharma company? Any speculations? Asking for a friend! 🙏 🥂
0 · Reply
Universaal
Universaal Jun. 18 at 6:42 PM
$ABSI I want to buy a starter, do they enough cash survive for 2 years and near term catalysts ? Thank you
1 · Reply
ArsenicSauce
ArsenicSauce Jun. 17 at 7:15 PM
$ABSI bought 11000 shares
0 · Reply